Chloé Grasselly will present her PhD work on In vivo activity of combinations of cytotoxic regimens with anti-PD1 and anti-PDL1 in various syngeneic cancer models, during the Session PO.IM02.02 – Immune Checkpoints 2 at the American Association for Cancer Research Annual Metting, in Chicago, USA, on April 14th to 18th.

You can visit her poster at the Section 32, Poster number 2723/15.